Event Summary

We look forward to seeing you at the2019 HFSA Comprehensive Heart Failure Review Course and Update on October 24-27, 2019 at the Westin Tampa Waterside in Tampa, FL. Please take some time to review the information below to help maximize your conference experience. View Program >>

ATTENDEES: To access additional resources, please make sure you are logged in.


The 2019 Comprehensive Heart Failure Review Course builds upon HFSA’s successful 2017 Review and 2018 Board Review Courses by incorporating results of new research studies, increasing focus on practical management recommendations, addressing issues encountered in practice, adding case studies, and providing breakout sessions in areas of special interest.


Thursday, October 24th, 4:00 PM – 8:30 PM
Friday, October 25th, 7:00 AM – 5:15 PM
Saturday, October 26th, 7:30 PM – 5:35 PM
Sunday, October 27th, 7:00 AM – 11:00 AM

Accreditation Statement 


custom image

The Heart Failure Society of America is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Heart Failure Society of America designates this live activity for a maximum of 18.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component and post-test with 75% passing score, enables the participant to earn up to 18.50 MOC points in the Maintenance of Certification (MOC) program.


This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)

This activity is approved for 18.50 contact hours.

Approval through 10/23/2021; ONA #22787


custom image

The University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). This event is accredited for 14.75 contact hours of knowledge-based CPE. To earn credit, participants must complete the online evaluation for each presentation attended on ipharmCE.UCDenver.edu. Pharmacist participants will receive instructions for accessing the evaluations. Once evaluations are completed, CPE will be uploaded to CPE monitor within 2 days.

Friday, October 25, 2019

Acute and Chronic Heart Failure 8:00 a.m.

ACPE# 0008-9999-19-131-L01-P (2.5 contact hours – knowledge-based)

Pulmonary Hypertension and Right Ventricular Failure 12:30 p.m.

ACPE# 0008-9999-19-132-L01-P (1.5 contact hours – knowledge-based)

Advances in Patient Monitoring-A Focus in the Heart Failure Patient 3:25 p.m.

ACPE# 0008-9999-19-133-L01-P (1.5 contact hours – knowledge-based)

Saturday, October 26, 2019

Cardiogenic Shock, Transplant, and Mechanical Circulatory Devices 8:00 a.m.

ACPE# 0008-9999-19-134-L01-P (1.5 contact hours – knowledge-based)

Cardiogenic Shock, Transplant, and Mechanical Circulatory Devices (Part 2) 10:50 a.m.

ACPE# 0008-9999-19-135-L01-P (2.0 contact hours – knowledge-based)

SPECIAL SESSION ‐ Patient Preferences 1:45 p.m.

ACPE# 0008-9999-19-136-L01-P (0.75 contact hours – knowledge-based)

HF and Arrhythmia Management 2:30 p.m.

ACPE# 0008-9999-19-137-L01-P (1.5 contact hours – knowledge-based)

Sunday, October 27, 2019

Special Populations 7:30 a.m.

ACPE# 0008-9999-19-138-L01-P (2.0 contact hours – knowledge-based)

Transitional & Palliative Care 9:35 a.m.

ACPE# 0008-9999-19-116-L01-P (1.5 contact hours – knowledge-based)

**No partial credit will be available. You must attend full day of sessions to receive credit** 

Learning Objectives

At the conclusion of this educational activity, participants will be able to:

  1. Describe the epidemiology of heart failure and implement strategies for the prevention of heart failure.
  2. Describe the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms.
  3. Assess and track the patient with acute or advanced heart failure, using non-invasive and invasive tests and biomarkers.
  4. Implement guideline-based therapy for patients with chronic heart failure, including pharmacologic agents and non-pharmacologic options, such as diet and exercise; and implantable devices.
  5. Apply appropriate care strategies for patients with pulmonary hypertension, RV failure, heart failure with preserved ejection fraction, cardiorenal syndrome, peripartum and infiltrative myopathies.
  6. Manage comorbidities in patients with chronic heart failure, including sleep disordered breathing, anemia, and depression.
  7. Implement strategies for effective disease management of the patient with advanced heart failure, including palliative care and transition to outpatient care.
  8. Describe characteristics of optimal candidates for cardiac transplantation or mechanical circulatory support.
  9. Apply strategies for atrial and ventricular arrhythmia management.
  10. Practice effectively in the context of health care reform and merit-based incentives.


ABMS core competencies:

  • Patient care
  • Medical knowledge
  • Interpersonal and communication skills
  • Professionalism
  • Systems‐based

ABIM‐specified competency areas in advanced heart failure and transplant cardiology:

  • Epidemiology and risk factors
  • Pathophysiology of heart failure
  • Hemodynamics and hemodynamic monitoring
  • Heart failure and normal ejection fraction
  • Heart failure with renal dysfunction/cardiorenal syndrome
  • Diagnostic tests and procedures
  • Acute decompensation of chronic heart failure
  • Heart failure comorbidities
  • Cardiomyopathies
  • Pharmacotherapy
  • Implantable devices
  • Heart transplant
  • Mechanical circulatory